Skip to main content
JW PHARMACEUTICAL logo

JW PHARMACEUTICAL — Investor Relations & Filings

Ticker · 001060 ISIN · KR7001060003 KO Manufacturing
Filings indexed 310 across all filing types
Latest filing 2022-10-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 001060

JW Pharmaceutical is a company focused on the research, development, and commercialization of pharmaceutical products. It provides a broad portfolio of therapeutic drugs, including specialty medicines and over-the-counter (OTC) solutions. Key product areas include nutritional infusions (Combiflex®, Winuf®), treatments for neutropenia (Neutrogin®), and cardiovascular medicines (Livalo®). Its consumer healthcare offerings feature the Hi-mom® brand of advanced wound care products. The company emphasizes innovation, advancing a pipeline of new drugs targeting oncology and immune diseases. This research is driven by proprietary technology platforms and includes candidates such as the gout treatment Epaminurad.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자 결정), outlining the number of new shares, issuance price, purpose of funds, and third-party allocation details. This falls under the category of announcements regarding new share issues or capital changes.
2022-10-20 Korean
채무인수결정
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding a 'Debt Assumption Decision' (채무인수결정) by JW Pharmaceutical. It details the amount, the relationship with the debtor (a subsidiary), and the board resolution date. This type of corporate disclosure regarding financing arrangements and debt obligations falls under the category of capital and financing updates.
2022-09-26 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report on Changes in Shareholding by Major Shareholders and Related Parties). This is a regulatory filing in South Korea that discloses changes in the share ownership of major shareholders, executives, and related parties. This falls under the category of Major Shareholding Notification (MRQ) as it details the change in ownership levels of significant shareholders.
2022-09-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by insiders or major shareholders to disclose changes in their shareholdings. This falls under the category of 'Director's Dealing' (DIRS) as it reports the acquisition of shares by a major shareholder (JW Holdings) in the issuing company (JW Choongwae Pharma).
2022-09-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-09-05 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) regarding the scheduling of an upcoming Investor Relations (IR) meeting. It provides the date, time, and purpose of the meeting, and explicitly states that the actual presentation materials will be posted on the company website at a later date. Following the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the presentation itself, making it a Report Publication Announcement (RPA).
2022-08-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.